Bausch & Lomb U.K Limited

Bausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK
Telephone: +44 (0)208 781 2900
Fax: +44 (0)208 781 2901
Medical Information Direct Line: +44(0)1748 828849 or 08 1871 9318
Medical Information e-mail: medicalinformationuk@bausch.com
Customer Care direct line: +44 (0)208781 2991

Summary of Product Characteristics last updated on the eMC: 30/07/2008
SPC Minims Dexamethasone sodium phosphate 0.1% w/v

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/07/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Jan-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Sections 4.4, 4.5 and 4.8 : addition of undesirable effects: risk of corneal deposits or corneal opacity with patients presenting with compromised cornea and receiving polypharmacy.

Section 10: update of revision date: 01/2008

Updated on 29/09/2003 and displayed until 30/07/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 30/07/2001 and displayed until 29/09/2003
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 06/09/1999 and displayed until 30/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   dexamethasone sodium phosphate